- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x IMD: IMIDAZOLE(Non-covalent)
- 5 x CL: CHLORIDE ION(Non-functional Binders)
CL.2: 4 residues within 4Å:- Chain A: L.161, F.184, P.185, Q.186
Ligand excluded by PLIPCL.3: 5 residues within 4Å:- Chain A: F.45, R.46, M.49, K.243, F.244
Ligand excluded by PLIPCL.5: 5 residues within 4Å:- Chain B: L.50, P.57, S.69, L.70, L.71
Ligand excluded by PLIPCL.6: 4 residues within 4Å:- Chain B: L.161, F.184, P.185, Q.186
Ligand excluded by PLIPCL.11: 5 residues within 4Å:- Chain C: F.45, R.46, M.49, K.243, F.244
Ligand excluded by PLIP- 4 x NA: SODIUM ION(Non-functional Binders)
NA.7: 5 residues within 4Å:- Chain B: F.45, R.46, M.49, K.243, F.244
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:F.244
- Water bridges: B:R.46, B:G.242
NA.10: 7 residues within 4Å:- Chain C: T.169, T.170, V.171, F.192, A.193, N.194, S.195
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:V.171, C:A.193, C:N.194, C:S.195
NA.13: 4 residues within 4Å:- Chain D: L.161, F.184, P.185, Q.186
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Q.186, D:Q.186
NA.14: 5 residues within 4Å:- Chain B: E.281, A.284
- Chain D: D.103, R.280, W.283
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain B- Water bridges: D:D.103, B:E.281
- 2 x TCL: TRICLOSAN(Non-covalent)
TCL.8: 14 residues within 4Å:- Chain A: L.220, L.225, F.238, L.252, I.256, V.261, F.263
- Chain B: L.220, L.225, F.238, L.252, I.256, V.261, F.263
10 PLIP interactions:6 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:L.225, A:L.252, A:I.256, A:F.263, A:F.263, A:F.263, B:L.252, B:F.263, B:F.263, B:F.263
TCL.15: 13 residues within 4Å:- Chain C: L.220, L.225, F.238, L.252, I.256, V.261, F.263
- Chain D: L.220, L.225, F.238, I.256, V.261, F.263
10 PLIP interactions:4 interactions with chain D, 6 interactions with chain C- Hydrophobic interactions: D:L.225, D:F.263, D:F.263, D:F.263, C:L.225, C:L.252, C:I.256, C:F.263, C:F.263, C:F.263
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sippel, K.H. et al., Crystal structure of the human Fatty Acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibition. J.Biol.Chem. (2014)
- Release Date
- 2014-10-15
- Peptides
- Enoyl-[acyl-carrier-protein] reductase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x IMD: IMIDAZOLE(Non-covalent)
- 5 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 2 x TCL: TRICLOSAN(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sippel, K.H. et al., Crystal structure of the human Fatty Acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibition. J.Biol.Chem. (2014)
- Release Date
- 2014-10-15
- Peptides
- Enoyl-[acyl-carrier-protein] reductase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D